March 2015 - Cancer Currents Blog
- A Week of Excitement and Hope: Communicating the Story of Cancer
Peter Garrett, acting director of NCI's communications office, discusses the Annual Report to the Nation on the Status of Cancer and activities surrounding the broadcast of the documentary film, Cancer: The Emperor of All Maladies.
- FDA Approves First Therapy for High-Risk Neuroblastoma
The FDA has approved dinutuximab as part of first-line therapy for children with high-risk neuroblastoma.
- FDA Approves First Immunotherapy Treatment for Lung Cancer
The FDA has approved nivolumab to treat patients with advanced non-small cell lung cancer that has progressed during or after treatment with platinum-based chemotherapy.
- The Exceptional Responders Initiative: Welcoming More Cases
The initiative is studying tissue, clinical, and genomic data from patients with cancer who have had dramatic and long-lasting responses to standard and experimental treatments that were not seen in similar patients who received the same treatment.
- Who Will Respond to PD-1 Inhibition? Study Provides Clues
A new study shows that specific DNA changes in a tumor may help determine which patients are most likely to respond to treatment with PD-1 inhibitors
- FDA Approves Panobinostat for Some Patients with Multiple Myeloma
The FDA granted accelerated approval of panobinostat for the treatment of multiple myeloma that has progressed after at least two prior standard therapies.
- DNA "Minicircles" Could Improve Cancer Detection, Study Suggests
Injecting customized DNA “rings” into tumor-bearing mice caused the tumor cells to release a biomarker that can be detected with a simple blood test.
- Smoking’s Disease Burden: Worse than Previously Thought?
According to a new study, smoking may be responsible for far more deaths each year than previously thought.
- Treatment Helps Preserve Fertility for Some Women with Breast Cancer
In a large clinical trial, giving a hormone-suppressing drug helped some younger women with breast cancer get pregnant after completing cancer treatment.
- Conference Report: Pursuing Progress Against HIV-Related Cancers
At the recent annual Conference on Retroviruses and Opportunistic Infections, several NCI researchers and NCI-funded investigators presented important new findings on HIV-related cancers.
- FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid Cancer
The FDA has approved lenvatinib (Lenvima) to treat some patients with the most common type of thyroid cancer.